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Itch is a distinct aversive sensation that elicits a strong urge to scratch. Despite recent
advances in our understanding of the peripheral basis of itch, we know very little regarding
how central neural circuits modulate acute and chronic itch processing. Here we establish the
causal contributions of deﬁned periaqueductal gray (PAG) neuronal populations in itch
modulation in mice. Chemogenetic manipulations demonstrate bidirectional modulation of
scratching by neurons in the PAG. Fiber photometry studies show that activity of GABAergic
and glutamatergic neurons in the PAG is modulated in an opposing manner during
chloroquine-evoked scratching. Furthermore, activation of PAG GABAergic neurons or inhibition of glutamatergic neurons resulted in attenuation of scratching in both acute and
chronic pruritis. Surprisingly, PAG GABAergic neurons, but not glutamatergic neurons, may
encode the aversive component of itch. Thus, the PAG represents a neuromodulatory hub
that regulates both the sensory and affective aspects of acute and chronic itch.
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tch is a distinct unpleasant sensation that evokes a strong
desire to scratch1. While acute itch is posited to play an
important physiological role as a defense mechanism, chronic
itch disorders are disabling and often difﬁcult to treat. Chronic
itch (pruritus) disorders affect 15% of the population are often
associated with neuropathy, skin disease, and organ dysfunction
and are the most frequent cause of visits to dermatologists2.
Antihistamines are the ﬁrst-line treatment for itch, but fail to
control most forms of chronic pruritus2. Recently, nonhistaminergic pathways for itch have been identiﬁed. Effective
alternative therapies that target non-histaminergic pathways are
not yet available3–5.
The neural pathways that signal itch and pain appear
remarkably similar, and signiﬁcant advances have recently been
made to tease apart itch and pain circuitry at the level of the
primary afferent ﬁbers and the spinal cord3–5. However, whether itch and pain information are integrated into the same or
different neuronal populations is currently a matter of controversy. In agreement with the concept of shared processing
nodes, recent studies support the notion of a robust itch
modulatory system within regions of the nervous system that
are related to nociception6–13. For example, scratching the skin
reduces the ﬁring rate of primate spinothalamic tract (STT)
neurons responding to pruritogens, but does not alter neuronal
responses to painful stimuli14. In addition, inhibition or
transection of the upper cervical spinal cord reduces scratchevoked inhibition of spinal cord neuronal activity induced by
pruritic stimuli, suggesting that the inhibitory effect of
scratching is due to the engagement of a strong descending
supraspinal inﬂuence on spinal itch processing15. The nature of
this supraspinal itch modulatory system is not known, but the
similarities in anatomical pathways for pain and itch provide a
framework for testable hypotheses.
Neuroimaging studies suggest that the periaqueductal gray, an
evolutionarily conserved structure in the midbrain, may mediate
the suppression of itch induced by noxious counter-stimuli such
as cold and scratching16–18. The ventrolateral periaqueductal gray
(vlPAG) has been shown to regulate several complex behaviors
including pain19 and is a major site of endogenous opioidinduced pain suppression20. Electrical stimulation of the PAG
produces profound analgesia21,22 by modulating spinal nociceptive transmission in part by descending projections to the rostral
ventromedial medulla (RVM), which sequentially projects to the
spinal cord23–26. It has been demonstrated in cats that27 the
magnitude of the response to a pruritic stimulus is greatly
diminished following decerebration, suggesting the existence of a
descending itch modulation system. Consistent with this idea,
electrical stimulation of the PAG results in inhibition of spinal
neurons responsive to intracutaneous delivery of histamine28, and
this inhibition is lost upon termination of PAG stimulation,.
Although the importance of the PAG in pruritic modulation is
established, very little is known regarding how the PAG participates in pruritic processing. An understanding of the midbrain
neural circuits and transmitters that underlie the suppression of
itch may identify novel targets for the treatment of pruritus, in a
manner similar to the advancement of opioid receptor pharmacology from our understanding of the role of the PAG in pain
modulation29–32.
Here, we use pharmacological, cell type-speciﬁc chemogenetic
manipulations and optical imaging approaches to functionally
identify and dissect the involvement of speciﬁc PAG neuronal
subpopulations in the modulation of acute and chronic itch. The
results that follow highlight the bidirectional modulation of
scratching behaviors by PAG neurons, with opposing roles of
glutamatergic and GABAergic subpopulations in mediating the
sensory component of itch. Further, we identify a unique role for
2

GABAergic PAG neurons in the encoding or modulation of itchrelated aversion.
Results
Bidirectional modulation of itch-related behaviors by vlPAG.
To determine the overall contribution of the vlPAG to itch processing, we performed bilateral microinjection of 4% lidocaine
(a short acting Na+ channel blocker) into the vlPAG to block
neuronal activity during pruritogen-induced scratching. Bilateral
lidocaine microinjection into the vlPAG signiﬁcantly attenuated
scratching evoked by intradermal injection of the nonhistaminergic pruritogen chloroquine (200 µg/50 µl) (Fig. 1a, e,
f). Vehicle microinjection into the vlPAG did not produce any
changes in chloroquine evoked scratching (Fig. 1d, f).
While this result suggests the importance of the vlPAG in
regulating pruritogen-evoked scratching, the nature of lidocaine
action raises the question of whether resident neurons within the
vlPAG or ﬁbers of passage within the vlPAG contribute to itch
processing. We therefore turned to a chemogenetic approach to
selectively activate or inhibit resident vlPAG neurons. AdenoAssociated Virus type 8 (AAV8) vectors carrying neuron-speciﬁc
stimulatory (hM3Dq) or inhibitory (hM4Di) DREADDs fused
with mCherry (AAV8-hSyn-hM3Dq/hM4Di-mCherry)33 were
microinjected bilaterally into the vlPAG (Fig. 2a, e). In animals
expressing the stimulatory DREAAD (hM3Dq), clozapine-Noxide (CNO) injection (1 mg/kg, i.p) resulted in a signiﬁcant
reduction in chloroquine evoked scratching (Fig. 2b, c,). This
reduction was dose dependent (Supplementary Fig. 1a). As a
control, and to rule out any possibility of CNO having any effect
on chloroquine evoked scratching, we administered CNO to mice
injected with an EGFP control virus (AAV8-hSyn-eGFP) and
observed no signiﬁcant effect on chloroquine-evoked scratching
behavior. The reduction in chloroquine-evoked scratching in
hM3Dq-injected mice after CNO administration signiﬁcantly
correlated with the number of hM3Dq-mCherry+ vlPAG
neurons. (R2 = 0.66, P = 0.0001, Fig. 2d). In contrast, CNO
(1 mg/kg, i.p) administration in mice expressing the inhibitory
DREAAD (hM4Di) in the vlPAG, resulted in a signiﬁcant
increase in chloroquine evoked scratching (Fig. 2f, g), compared
to mice expressing the control EGFP vector in the vlPAG. The
CNO-mediated increase in chloroquine-evoked scratching in
mice expressing the inhibitory DREAAD (hM4Di) in the vlPAG
was dose-dependent (Supplementary Fig. 1b), and again, this
increase in chloroquine-evoked scratching in hM4Di-injected
mice after CNO administration demonstrated a signiﬁcant
correlation with the number of hM4Di-mCherry+ vlPAG
neurons. (R2 = 0.38, P = 0.01, Fig. 2h). The results showing that
targeted inhibition of resident vlPAG neurons results in increased
scratching is in stark contrast to the results from the lidocaine
experiment described above, where inactivation of vlPAG
(including both resident neurons and ﬁbers of passage) led to
reduced scratching. These ﬁndings illustrate the importance of
using cell-speciﬁc approaches, and demonstrate that activating
vlPAG neurons attenuates pruritus, while inhibiting vlPAG
neurons potentiates pruritic behaviors
Itch-induced aversion is blocked by activation of vlPAG. Itch is
an unpleasant emotional experience in humans. We adapted a
conditioned place aversion (CPA) paradigm to evaluate the
unpleasant affective component of itch in mice (Supplementary
Fig. 2a). We hypothesized that chloroquine-induced itch would
produce negative reinforcement. Mice were placed in a 3chamber CPA arena and given free access to all chambers on day
one. The mice were then paired with saline injection or chloroquine injection in separate chambers distinguishable by vertical
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Fig. 1 Pharmacological inactivation of the vlPAG attenutates scratching behavior. a Representation of bilateral placement of guide cannulae in the vlPAG in
mice injected with vehicle/lidocaine. b Representative histological veriﬁcation showing bilateral microinjection of lidocaine into the vlPAG. c Experimental
timeline for examination of behavioral effects of bilateral microinjection of lidocaine into the vlPAG on chloroquine evoked scratching. d, e Histograms
demonstrating the mean number of scratching bouts per minute for a 30-min period. d Microinjection of vehicle (0.9% saline) into vlPAG did not produce
any effects on chloroquine evoked scratching when compared to baseline and 24-hour post-vehicle treatment. e Microinjection of lidocaine into vlPAG
resulted in signiﬁcant suppression of chloroquine evoked scratching when compared to baseline and 24-hour post-lidocaine treatment. f Summary
quantiﬁcation of vehicle and lidocaine microinjection effects on chloroquine evoked scratching. Data represents the total number of chloroquine evoked
scratching bouts per individual mouse at prior to treatment, following injection of vehicle/lidocaine, or 24 h post-treatment with lidocaine (orange squares)
or vehicle (green circles) treatment (N = 8 per group, two-way ANOVA, P < 0.0001 after lidocaine microinjection; Interaction; F (2, 14) = 26.46, ***P <
0.0001. Pre vs. Post Lidocaine; F (2, 14) = 14.26, ^^^P < 0.0001. Vehicle vs. Lidocaine; ###F (2, 24) = 4.71, P = 0.0001). Values in the gray shaded areas
represent the mean ± SEM of all animals, for which individual values are shown in the un-shaded areas (horizontal lines represent means). Source data are
available as a Source Data ﬁle

or horizontal stripes for three subsequent days. Twenty-four
hours after the last pairing, mice were given free access to all
chambers and the time spent in each chamber was recorded.
Consistent with our hypothesis, mice exhibited robust aversion to
the chamber paired with chloroquine injection compared to the
chamber paired with saline injection (Supplementary Fig. 2b & c).
CPA to chloroquine was dose dependent; 50 µg/10 µl chloroquine
did not show CPA while doses of 200 µg and 400 µg/10 µl produced signiﬁcant CPA (Supplementary Fig. 2c). All groups spent
an equivalent time in the neutral chamber. These results suggest
that chloroquine produces reliable, robust place aversion, consistent with a recent report34.
Having demonstrated that chemogenetic activation of vlPAG
neurons suppresses chloroquine-induced scratching, we next
asked whether chemogenetic activation of vlPAG neurons would
abolish place aversion to chloroquine. We transduced vlPAG
neurons bilaterally with AAV8 vectors carrying either the
stimulatory DREADD (hM3Dq) fused with mCherry or control
AAV8 EGFP. After free access to both chambers on day 1, mice
were conditioned for 3 days, by administering either saline or
chloroquine. On conditioning days, mice were pre-treated with
either saline or CNO (i.p) 1 h before being paired in the speciﬁed
chambers with saline or chloroquine injection (Fig. 3a). When
tested on day 5 after conditioning, animals expressing the control
EGFP construct demonstrated robust place aversion to chloroquine + CNO, similar to what was seen in naïve mice (Fig. 3b, c,
n = 13, t test, p = 0.0219). In contrast, animals expressing the
stimulatory DREADD hM3Dq in the vlPAG showed no aversion
to the chloroquine + CNO-paired chamber, (Fig. 3d, e, n = 13,
t test, p = 0.9859). These results demonstrate that activation of

hM3Dq in vlPAG neurons blocks place aversion to chloroquine
and suggest that activation of vlPAG neuronal circuitry attenuates
the unpleasant affective component of itch.
Ca2+ dynamics of vlPAG cell-types in itch processing. The
results above show that excitation of vlPAG neurons leads to
suppression of chloroquine-evoked scratching, whereas inhibition
of vlPAG neuronal activity potentiates chloroquine-evoked
scratching. However, the vlPAG is composed of both inhibitory
GABAergic and excitatory glutamatergic neurons, which are nonoverlapping populations35–37. The chemogenetic manipulations
of vlPAG neuronal activity in the prior experiments do not distinguish between these two populations. To investigate the
potential for differential roles of vlPAG GABAergic and glutamatergic neurons in the regulation of itch behaviors, we used
ﬁber photometry38 to measure bulk Ca2+ dynamics in a cell typespeciﬁc manner in awake, behaving mice. By expressing the
genetically encoded calcium indicator, GCaMP6s, in GABAergic
(Vgat-IRES-Cre) or glutamatergic (Vglut2-IRES-Cre) neurons,
we can measure neuronal activity-dependent population ﬂuorescence changes in speciﬁc cell types within the vlPAG while mice
are engaged in pruritogen-induced scratching. We virally
expressed GCaMP6s in Vgat+ or Vglut2+ vlPAG neurons by
injecting Cre-dependent AAV (AAV-DJ EF1a-DIO-GCaMP6s)
into the vlPAG of Vgat-Cre or Vglut2-Cre mice. An optical ﬁber
was implanted unilaterally above the vlPAG to measure changes
in Ca2+ dynamics during chloroquine-evoked scratching (Fig. 4a,
b). Mice expressing GCaMP6s in either Vgat or Vglut2 neurons
were acclimated to a behavioral chamber and injected
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Fig. 2 Chemogenetic manipulation of vlPAG neurons can modulates itch. a Schematic and representative coronal section image showing viral targeting of
AAV8 hM3Dq–mCherry transgenes bilaterally injected into the vlPAG, scale bar represents 375 µM. b CNO (1 mg/kg, i.p) administration resulted in a
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any effects on the number of scratches induced by chloroquine injection in mice expressing the control eGFP construct Interaction; F (1, 21) = 25.24, ***P <
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intradermally with chloroquine. We found that vlPAG Vgat+
and Vglut2+ neurons showed opposing responses during
chloroquine-evoked scratching. Vgat+ vlPAG neurons showed
signiﬁcant decreases of Ca2+ transients during chloroquineevoked scratching bouts. These decreases in Ca2+ signals began
immediately following the initiation of scratching bouts and
lasted for 30 s on average (Fig. 4c–e, h). Vglut2+ vlPAG neurons
showed the opposite response, wherein chloroquine-evoked
scratching bouts resulted in signiﬁcant and long-lasting increases in Ca2+ transients, beginning at the onset of the scratching
behaviors (Fig. 4c, f, g, i). We did not observe similar robust
changes in Ca2+ dynamics during spontaneous scratching bouts
in the Vgat+ neurons prior to chloroquine evoked scratching
(Supplementary Fig. 3). The decrease in the Vgat Ca2+ activity
was signiﬁcantly greater during chloroquine-evoked scratching
events compared to these spontaneous scratches recorded prior to
chloroquine injection. We tested the itch-speciﬁc nature of these
changes in vlPAG calcium dynamics by quantifying changes in
ﬂuorescence of the same neuronal populations during grooming
or wiping behaviors. At the onset of grooming or wiping, Ca2+
dynamics were variable but not signiﬁcantly changed, suggesting
that the ﬂuorescence changes described above are functionally
related to chloroquine-induced scratching (Fig. 4j, i). To further
verify that changes observed in Vgat+ and Vglut2+ vlPAG
neurons are correlated with chloroquine-evoked scratching
4

behaviors, we generated randomly assigned arbitrary bout events
and aligned Ca2+ transients to these arbitrary bouts. Ca2+
dynamics of Vgat+ and Vglut2+ vlPAG neurons were not signiﬁcantly correlated with these arbitrarily created bouts (Fig. 4k,
m). Altogether these data suggest that vlPAG Vgat+ and Vglut2+
neurons respond differently during chloroquine-evoked scratching. Our results capture the rapid changes in activity that these
neurons undergo in response to chloroquine-evoked scratching
and suggest that a cell type-speciﬁc approach is needed to
understand the role of vlPAG neurons in sensory and affective
aspects of itch.
vlPAG GABAergic neurons modulate acute and chronic itch.
The ﬁber photometry studies described above show a decrease in
activity of Vgat+ neurons during chloroquine-evoked scratching,
suggesting a potential role for reduced GABAergic transmission
in the vlPAG in itch processing. To test the hypothesis that
altered vlPAG GABAergic activity regulates scratching behaviors,
we introduced Cre-dependent viral constructs containing either
DREADDs fused to mCherry or control construct lacking the
DREADD (Syn-mCh) into the vlPAG of Vgat-IRES-Cre mice
(Fig. 5a). We have recently shown that CNO reliably modulates
the activity of vlPAG GABAergic neurons expressing
DREADDs36. We selectively activated vlPAG GABAergic

NATURE COMMUNICATIONS | (2019)10:4356 | https://doi.org/10.1038/s41467-019-12316-0 | www.nature.com/naturecommunications

ARTICLE

NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12316-0

a

Day 1

Free run

Day 2–4; AM

Saline/
Saline

Day 5

CNO/
Chloroquine

Free run

c

b
vlPAG::eGFP

vlPAG::eGFP
400

Post
Difference score (s)

Pre

Day 2–4; PM

*

0

–400

e
d
vlPAG::hM3Dq

vlPAG::hM3Dq
NS

Post
Difference score (s)

Pre

200

0

–300

Saline
Chloroquine

Fig. 3 Chemogenetic activation of vlPAG neurons can block aversive component of itch. a Schematic of conditioned place aversion experimental design in
AAV8 hM3Dq–mCherry and AAV8–eGFP injected animals. Mice received treatment with either i.p. saline or CNO 90 min before pairing the mice in the
chambers with saline or chloroquine, respectively. b Representative heat map showing spatial location of a control mouse injected with AAV8–EGFP, pre
and post chloroquine conditioning. c After CNO (0.5 mg/kg, i.p) administration in vlPAG::eGFP mice, difference scores indicate mice spent signiﬁcantly
less time in the chloroquine paired chamber compared to saline paired chamber (N = 13, t test, t = 2.128 df = 24, *P = 0.0219). d Representative heat map
showing spatial location of a mouse injected with AAV8–hM3Dq, pre and post chloroquine conditioning. e Activation of vlPAG::hM3Dq neurons with CNO
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neurons via expression of the Cre-dependent excitatory
DREADD hM3Dq in the vlPAG (Fig. 5a). In vivo CNOdependent (5 mg/kg, i.p.) activation of vlPAG Vgat+ neurons
resulted in a signiﬁcant decrease in chloroquine-evoked scratching compared to baseline (Fig. 5b, c). The reduction in chloroquine evoked scratching in hM3Dq-injected mice after CNO
administration is dose dependent (Supplementary Fig. 1c) and
signiﬁcantly correlated with the number of hM3Dq-mCherry+
vlPAG neurons (R2 = 0.68, P = 0.0004, Fig. 5d). These results
suggest that chloroquine-induced scratching can be suppressed by
the activation of Gq signaling in GABAergic vlPAG neurons. We
next asked what would happen to chloroquine-evoked scratching
if we decreased the activity of vlPAG Vgat+ neurons. Three weeks
after viral infection of vlPAG neurons with a Cre-dependent viral
vector for the inhibitory DREADD hM4Di, we observed restricted expression of hM4Di-mcherry in GABAergic neurons within
the vlPAG of Vgat-Cre mice (Fig. 5a). Inhibition of vlPAG
GABAergic neurons with CNO (5 mg/kg; i.p) resulted in a robust
increase in chloroquine-evoked scratching compared to baseline
(Fig. 5e, f). Potentiation of chloroquine-evoked scratching in

hM4Di-injected mice after CNO administration is dose dependent (Supplementary Fig. 1d) but not signiﬁcantly correlated with
the number of hM4Di-mCherry+ vlPAG neurons (R2 = 0.1, P =
0.5, Fig. 5g). Mice expressing the control mCherry vector in the
vlPAG did not show any changes in scratching behavior following
CNO administration.
To investigate whether activation of vlPAG GABAergic
neurons can attenuate chronic itch, we used a dry skin model
of itch. Chronic spontaneous scratching develops following daily
topical application of acetone/ether/water (AEW) for 7 days39–41.
Seven days after AEW treatment, Vgat::mCh-injected and Vgat::
hM3Dq-injected mice showed robust spontaneous scratching. On
day 8, chemogenetic activation of vlPAG GABAergic neurons
with CNO (5 mg/kg, i.p.) resulted in a signiﬁcant reduction of
spontaneous scratching behavior produced by AEW treatment
(Fig. 5h). In Vgat::mCherry mice, CNO administration did not
affect spontaneous scratching behavior produced by AEW
treatment.
We next tested whether chemogenetic activation of vlPAG
GABAergic neurons would block the aversive component of
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chloroquine-induced itch. We performed CPA to chloroquine in
Vgat::hM3Dq and Vgat::mCherry mice. During conditioning,
mice were pre-treated with either saline or CNO (i.p) 1 h before
being placed in the saline or chloroquine paired chamber (Fig. 6a).
When allowed free access to both chambers following conditioning, Vgat::hM3Dq-injected mice spent similar time in both
chambers whereas Vgat::mCherry-injected controls spent signiﬁcantly less time in the chamber that was paired with
chloroquine (Fig. 6b, c, d and e). Neither Vgat::hM3Dq nor
Vgat::mCherry showed any change in chamber preference from
their initial exploration. Neither group showed altered locomotor
activity following CNO administration. These results demonstrate
that activation of vlPAG GABAergic neurons attenuates place
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aversion to chloroquine and suggest that these neurons modulate
the aversive component of itch.
vlPAG glutamatergic neurons modulate acute and chronic itch.
The increases in vlPAG Vglut2+ neuronal activity observed
during scratching (ﬁber photometry recordings above) suggest a
potential causal relationship between activity of these neurons
and chloroquine-evoked scratching behaviors (Fig. 4c, i). To test
this hypothesis, we expressed Cre-dependent hM3Dq-mCherry or
a control virus lacking the DREADD (Syn-mCh) selectively in
glutamatergic (Vglut2-expressing) vlPAG neurons (Fig. 7a) and
asked if increasing the activity of Vglut2 neurons could augment
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chloroquine evoked scratching bouts. Dark shaded line indicates scratching bout. j Averaged GCAMP6s ﬂuorescence signal of Vgat+ve vlPAG neurons
after initiation of grooming bout. Trace plotted as mean ± SEM (shaded trace). k Averaged GCAMP6s ﬂuorescence signal of Vglut+ve vlPAG neurons after
initiation of grooming bout. Trace plotted as mean ± SEM (shaded trace), dark shaded line indicates grooming bout. l Averaged GCAMP6s ﬂuorescence
signal of Vgat+ve vlPAG neurons for arbitrarily generated bouts. Trace plotted as mean ± SEM (shaded trace). m Averaged GCAMP6s ﬂuorescence signal
of Vglut+ve vlPAG neurons for arbitrarily generated bouts. Trace plotted as mean ± SEM (shaded trace), dark shaded line indicates arbitrary bout. All values
are mean ± SEM. P < 0.0001. Scale bars represents 250 µM. Source data are available as a Source Data ﬁle

mCherry

hM3Dq

AEW

125

*#
^

0

hM4Di mCherry +ve
neurons

Pre

CNO

Fig. 5 vlPAG GABAergic neuronal activity modulates sensory component of itch. a Viral targeting of AAV5-hSyn-DIO-hM3Dq–mCherry, AAV5-hSyn-DIOhM4Di–mCherry and AAV5-hSyn-DIO-mCherry bilaterally into the vlPAG of Vgat Cre mice. Representative vlPAG sections showing restricted viral
expression of hM3Dq–mCherry and hM4Di–mCherry in the vlPAG of Vgat Cre mice. b CNO (5 mg/kg, i.p) had no signiﬁcant effect on chloroquine evoked
scratching in Vgat Cre mice expressing the control mCherry construct in the vlPAG. However, CNO (5 mg/kg, i.p) administration resulted in signiﬁcant
reduction in chloroquine evoked scratching in mice that express hM3Dq in the vlPAG of Vgat Cre mice. Interaction; F (1, 24) = 21.14, ^^P < 0.001. Pre vs.
CNO; F (1, 24) = 7.531, *P = 0.0113. mCherry vs. hM3Dq; F (1, 24) = 39.20, ***P < 0.0001. N = 13/group. Two-way ANOVA. c Heat map showing averaged
chloroquine-evoked scratching bouts pre-CNO and post-CNO. d Chloroquine evoked scratching in hM3Dq injected mice after CNO administration is
directly correlated with number of hM3Dq-mCherry+ neurons. R2 = 0.68, P = 0.0004. e Inhibition of vlPAG neurons by CNO (5 mg/kg, i.p) administration
resulted in a signiﬁcant increase in chloroquine evoked scratching in Vgat::hM4Di mice compared to baselines while control mCherry injected mice in the
vlPAG show no difference in chloroquine evoked scratching after CNO (5 mg/kg, i.p) administration. Interaction; F (1, 24) = 32.55, ^^^P < 0.0001. Pre vs.
CNO; F (1, 24) = 27.60, ###P < 0.0001. mCherry vs. hM4Di; F (1, 24) = 40.65, ***P < 0.0001. N = 13/group. Two-way ANOVA. f Heat map showing
averaged chloroquine-evoked scratching bouts pre-CNO and post-CNO in mice expressing hM4Di. g Chloroquine evoked scratching in hM4Di injected
mice after CNO administration is not correlated with number of hM4Di-mCherry+ vlPAG in the Vgat Cre mice. R2 = 0.1, P = 0.5. h Activation of vlPAG
GABAergic neurons with CNO (5 mg/kg, i.p.) resulted in a signiﬁcant reduction of spontaneous scratching behavior produced by AEW treatment. CNO
administration did not affect spontaneous scratching behavior produced by AEW treatment in control mCherry injected mice. Interaction; F (1, 14) = 9.056,
***P = 0.0094. Pre vs. CNO; F (1, 14) = 13.58, ^^P = 0.0024. N = 8/group. Two-way ANOVA. All values are mean ± SEM. Source data are available as a
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chloroquine-evoked scratching behavior. It is important to note
that we recently demonstrated that CNO reliably modulates the
activity of vlPAG glutamatergic neurons expressing DREADDs36.
Three weeks after DREADD injection, robust viral expression was
observed in the vlPAG (Fig. 7a). Activation of vlPAG Vglut2::
hM3Dq neurons via CNO (5 mg/kg, i.p.) led to a profound
increase in chloroquine-evoked scratching compared to baseline
(Fig. 7b, c). CNO administration in Vglut2::mCherry mice had no
effect on chloroquine-evoked scratching, indicating that elevated
glutamatergic activity in the vlPAG is sufﬁcient to enhance
chloroquine-evoked scratching. The increase in chloroquine
evoked scratching in hM3Dq-injected mice after CNO administration is dose dependent (Supplementary Fig. 1e) and signiﬁcantly correlated with the number of hM3Dq-mCherry+
vlPAG neurons (R2 = 0.39, P = 0.01, Fig. 7d).
Next, we assessed whether endogenous activity of vlPAG
Vglut2 neurons is necessary for regulating itch processing.
Inhibition of Vglut2 + vlPAG neurons in Vglut2::hM4Di mice
with CNO (5 mg/kg; i.p) resulted in a signiﬁcant decrease in
chloroquine-evoked scratching compared to baseline (Fig. 7e, f).
The CNO-mediated decrease in chloroquine-evoked scratching is
dose dependent (Supplementary Fig. 1f). Mice expressing the
control mCherry vector in vlPAG glutamatergic neurons show no
signiﬁcant change in scratching behavior upon CNO administration. These decreases also signiﬁcantly correlate with the
number of hM4Di-mCherry+ vlPAG neurons in Vglut2 Cre mice
(R2 = 0.45, P = 0.005, Fig. 7g).
We further analyzed whether inhibition of vlPAG glutamatergic neurons can affect scratching behaviors in the AEW dry skin
model of chronic itch. Vglut2::mCh-injected and Vglut2::hM4Diinjected mice showed robust spontaneous scratching seven days
after AEW treatment. Chemogenetic inhibition of vlPAG
glutamatergic neurons (Vglut2::hM4Di) with CNO (5 mg/kg,
8

i.p.) resulted in a signiﬁcant reduction of spontaneous scratching
behavior produced by dry skin (Fig. 7h). CNO administration in
Vglut2::mCherry mice did not lead to changes in spontaneous
scratching behavior produced by dry skin. These results
demonstrate that activity of vlPAG glutamatergic neurons is
necessary for acute and chronic itch processing.
To determine if chemogenetic inhibition of vlPAG glutamatergic neurons can block the aversive component of chloroquineinduced itch, we performed CPA to chloroquine in Vglut2::
hM4Di and Vglut2::mCherry mice (Fig. 8a). In contrast to what
we observed following modulation of vlPAG GABAergic neurons,
modulation of the activity of glutamatergic vlPAG neurons had
no detectable effect on place aversion induced by chloroquine.
Thus, when allowed free access to both chambers following
conditioning, both Vglut2::hM3Dq and Vglut2::mCherry injected
mice spent signiﬁcantly less time in the chloroquine-paired
chamber, suggesting that place aversion was not suppressed by
activation of vlPAG glutamatergic neurons. Neither Vglut2::
mCherry mice (Fig. 8b, d) nor Vglut2::hM3Dq (Fig. 8c, e) showed
any change in behavior from their initial exploration and neither
group showed altered locomotor activity following CNO administration. These results demonstrate that inhibition of vlPAG
glutamatergic neurons did not prevent place aversion to
chloroquine and suggest that vlPAG glutamatergic neurons do
not contribute to the aversive component of itch.
PAG neurons can modulate spinal pruritic processing. To
determine whether global manipulation of PAG neurons modulates pruritic processing via descending control at the level of the
spinal cord, we performed activity-dependent mapping studies
using cFos labeling (a surrogate marker for neuronal activity). We
found chloroquine injection induced cFos expression in the spinal
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cord, and that global chemogenetic activation of PAG neurons
suppressed this chloroquine-induced induction of spinal cFos
expression (Fig. 9b, d), whereas global chemogenetic inhibition of
PAG neurons lead to increases in the spinal cFos to chloroquine
stimuli (Fig. 9c, d). These results suggest that PAG neurons may
modulate spinal pruritic processing by descending projections to
the spinal cord via the rostral ventromedial medulla (RVM), as
suggested by recent work42.
Discussion
More than 70 years ago, the brainstem was shown to play a
crucial role in itch modulation27. Recent studies have acknowledged the presence of deﬁned neural circuits underlying itch
processing in the brainstem, supporting this hypothesis11,12,43. It
has been demonstrated that electrical stimulation of the PAG
suppresses responsiveness of spinal cord neurons to histamine28,
but the neural subtypes involved in modulating itch processing
have never been identiﬁed. Our initial experiment to test for a
role of the vlPAG in itch processing in mice utilized local

pharmacologic blockade of neuronal activity (lidocaine), and
supported the above studies suggesting a role for the PAG in itch
modulation. This approach lacks cell-type speciﬁcity, and additionally inhibits axons coursing through or nearby the injections
site. Our ﬁndings using global (not cell-type-speciﬁc) DREADD
manipulation of vlPAG neurons demonstrate that activation of
vlPAG neurons results in robust suppression of chloroquineevoked scratching, while inhibition of vlPAG neurons results in
profound potentiation of chloroquine-evoked scratching. This
approach eliminated the possible stimulation or inhibition of
axons coursing through the PAG that confounds studies utilizing
either electrical stimulation-induced activation or silencing via
cooling or local anesthetic administration. However, the experiments that followed demonstrate diverse roles for different cell
types in the vlPAG, in a manner not easily predicted from global
electrical, pharmacologic, or chemogenetic approaches described
here and previously.
The PAG comprises a diverse group of neuronal subpopulations
that express a variety of neurotransmitters and neuropeptides44–46.
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It is unclear how distinct neuronal populations integrate and
modulate different sensations. We and others have shown that the
vlPAG GABAergic and glutamatergic neurons differentially modulate pain neurotransmission29,30,35–37,47–51. Itch and pain exhibit a
reciprocal relationship at the behavioral level. For example, itch is
suppressed by the mild noxious mechanical stimulus of
scratching14,17,18,52. Given this inverse relationship of itch and pain
and these identiﬁed differential roles for these neuronal populations
in the vlPAG, we investigated the role of GABAergic and glutamatergic vlPAG neurons in the processing of itch. We observed that
vlPAG GABAergic and glutamatergic neurons exhibited opposing
effects on pruritic information processing. Activation of vlPAG
GABAergic neurons resulted in decreased chloroquine-induced itch
while their inhibition led to an increase in chloroquine-induced
itch. Conversely, activation of vlPAG glutamatergic neurons resulted in a profound increase in chloroquine-induced itch whereas
inhibition of these cells resulted in suppression of chloroquineinduced itch. Similar results were observed in a model of chronic
itch, where activation of vlPAG GABAergic neurons or inhibition of
vlPAG glutamatergic neurons resulted in attenuation of spontaneous scratching behavior produced by chronic dry skin. These
results indicate that decreased activity in vlPAG GABAergic and/or
increased activity of glutamatergic neurons may underlie central
sensitization of itch in the context of chronic itch. It is likely that the
vGlut2 + PAG neurons we studied here overlap with the Tac1+
neurons studied by Gao et al.42. They found that activating these
neurons produced spontaneous scratching, and as such it is possible
that Tac1+ neurons are small subset of vGlut2 + PAG neurons.
Taken together, we show evidence for the presence of functionally
divergent cell types in the vlPAG that modulate itch-evoked
behavioral output and the affective component associated with
pruritus. Thus, although pain and itch are processed and transmitted by similar neuroanatomical substrates at peripheral, spinal
and supraspinal sites, they are discriminated and processed distinctly at the cellular level.
The vlPAG is known to have neuronal subtypes that exhibit
different ﬁring patterns in response to noxious stimuli53,54.
Recently studies have shown that inhibition of vlPAG GABAergic
neurons or activation of glutamatergic neurons results in antinociception, whereas activation of vlPAG GABAergic neurons or
inhibition of glutamatergic neurons leads to hypersensitivity to
painful stimuli36. Interestingly, these results together with our
current ﬁndings demonstrate that vlPAG GABAergic and glutamatergic neurons process both pain and itch signals inversely.
The activity proﬁle of GABAergic and glutamatergic neurons was
regulated inversely during chloroquine-evoked scratching, as
determined here by measuring Ca2+ dynamics. The activity of
these neuronal populations is consistent with the behavioral
results of our chemogenetic experiments in scratching behavior,
suggesting that in vivo calcium imaging faithfully recapitulates
the activity of GABAergic and glutamatergic vlPAG neurons
during pruritic processing. A drawback of ﬁber photometry is
that it captures the averaged activity across a population of
neurons, which might lead to missing or masking any heterogeneity in the responses of individual neurons.
We found that vlPAG Vgat+ and Vglut2+ neurons showed
opposing responses during chloroquine-evoked scratching in our
photometry recordings. Chloroquine evoked scratching inhibits
GABAergic neurons and activates glutamatergic neurons. Interestingly, in GABAergic neurons basal activity is elevated just
preceding chloroquine evoked scratching, while this phenomenon
is not seen during spontaneous scratching bouts. What would be
the underlying cause for this? We propose that GABAergic
neuronal activity is encoding the sensory and motivational
aspects of itch and this activity is suppressed when scratched,
possibly contributing to relief of itch. An assumption in this
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model is that relief of itch by scratching is responsible for suppression of activity of GABAergic neurons. Interestingly, we
observed rapid elevated activity in the Vglut2+ neurons subsequent to scratching. These differences in the modulatory effects
of GABAergic and glutamatergic neurons on itch response suggests the presence of distinct microcircuit features. It is possible
that inhibition of Vgat+ neurons might disinhibit the Vglut2 +ve
neurons subsequent to scratching during chloroquine-evoked
itch. The Ca2+ dynamics of Vgat and Vglut2 neurons are consistent with a key role of these neurons in regulating itch
processing.
The opposing and unique actions of glutamatergic and
GABAergic neurons in the modulation of itch identiﬁed here
emphasize the importance of using cell-type-speciﬁc approaches.
This also suggests that further dissection of these neuronal subtypes should be undertaken. We have chosen to assess potential
unique roles for glutamatergic and GABAergic neurons for the
reasons mentioned above, however the PAG comprises multiple
neuronal populations expressing several neurotransmitters and
neuropeptides44–46. Even among the subpopulations studied here,
there are certain to be further subclassiﬁcations based on anatomy
(e.g., projection targets, source of synaptic inputs) or neurochemistry (e.g., neuropeptides or other co-expressed neuromodulators). It is unlikely that all the GABAergic and
glutamatergic vlPAG neurons show the same response to pruritic
processing. Prior work37,48–50 suggests that GABAergic neurons
in the PAG are mostly interneurons, and we did not ﬁnd any
downstream projections from these neurons in our studies. PAG
glutamatergic neurons are output neurons of the PAG. Differences in the modulatory effects of GABAergic and glutamatergic
neurons on itch responses suggest the presence of distinct
microcircuit features. Though not addressed directly in our study,
it is possible that activation of Vgat neurons that encode itch
might directly inhibit the Vglut2 neurons to suppress chloroquine
evoked ongoing itch. Future studies may discover additional
heterogeneity in GABAergic and glutamatergic neuronal subtypes
based on their gene expression and their anatomical downstream
targets.
There were some notable discrepancies between our behavioral
data obtained from pharmacological and chemogenetic manipulation of global PAG activity compared to cell-type speciﬁc PAG
manipulations (we have included additional discussion points in
the supplementary discussion).
Since itch, like pain, is an aversive sensory experience in
humans17,18,52, we hypothesized that pruritogen-evoked itch
would produce an aversive state in mice. Here we demonstrate
that itch evoked by chloroquine administration resulted in robust
conditioned place aversion, in a dose-dependent manner
demonstrating that in mice itch is fundamentally an aversive
sensation, consistent with recent studies34. We also demonstrated
that activation of vlPAG neurons abolishes CPA to chloroquine.
Furthermore, activation of vlPAG GABAergic neurons prevented
place aversion to chloroquine suggesting that vlPAG GABAergic
neurons encode the aversive component of itch. Surprisingly,
inhibition of vlPAG glutamatergic neurons did not prevent place
aversion to chloroquine, though chemogenetic inhibition of these
neurons decreased both acute and chronic itch. These results
indicate that vlPAG GABAergic neurons, but not glutamatergic
neurons, are capable of encoding the aversive component of itch.
The loss of chloroquine-induced aversion upon activation of
vlPAG GABAergic neurons could be due to activation of descending inhibition from vlPAG GABAergic neurons, leading to
suppression of transmission of chloroquine-evoked activity in
itch-speciﬁc sensory pathways at the level of the spinal cord.
Alternatively, the disruption of pruritogen-induced sensory
transmission could occur within the vlPAG itself. Indeed, activity
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of these neurons is suppressed in the context of chloroquineinduced scratching, as demonstrated by photometry recordings in
the vlPAG. Such an effect could be mediated by activation of
GABAergic projections from the vlPAG to the ventral tegmental
area (VTA) or to the amygdala neurons that encode aversion55.
Recent studies have also shown that VTA dopaminergic neurons
are involved in the motivational aspect of itch-evoked scratching56. Our results suggest that blockade of CPA could be due to a
reduction in the negative affect associated with chloroquineevoked scratching, or to suppression of transmission of sensory
information in itch-speciﬁc sensory pathways. Interestingly,
recent work using chemogenetic inhibition of vPAG GABAergic
neurons suggested that these neurons encode for aversive anxious
behaviors57.
Together, our data demonstrate that chloroquine-induced itch
is a fundamentally aversive sensation and can be suppressed by
activating vlPAG GABAergic neurons. We conclude that the
vlPAG is a hub that can bidirectionally modulate itch processing
in the context of acute and chronic itch. This differential modulation of itch by glutamatergic and GABAergic vlPAG neurons
is reciprocal in nature to the role of these same cell populations in
the modulation of pain36 (Fig. 10). Our results showing that
activation of vlPAG GABAergic neurons or inhibition of vlPAG
glutamatergic neurons can attenuate chronic itch suggesting that
disengagement in this circuit has the potential to contribute to
exacerbation of chronic itch.
The vlPAG is well-positioned to be modulated by top-down
control from neural regions important for processing pain and
itch1,9,17,18,24,29,52,58, including the somatosensory, anterior cingulate, and insular cortices, as well as the thalamus59,60. The
vlPAG has been shown to be instrumental in descending modulation of pain processing20,37. Our current observations identify
a previously unknown role of the vlPAG in modulation of itch
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Fig. 10 Summary of the effects of manipulation of global vs. cell typespeciﬁc activity in the vlPAG on pain and itch. a Global (non-cell-typespeciﬁc) chemogenetic activation of vlPAG neurons resulted in robust
suppression of itch and pain, while global chemogenetic inhibition of vlPAG
neurons resulted in profound increases in itch and pain behaviors.
b Activation of vlPAG GABAergic neurons attenuates itch and enhances
pain while inhibition of vlPAG GABAergic neurons leads to increased itch
and decreased pain. c Activation of vlPAG glutamatergic neurons leads to
enhanced itch and decreased pain behaviors, while inhibition of vlPAG
glutamatergic neurons attenuates itch and potentiates pain
12

Methods
Animals. All experiments were conducted in accordance with the National Institute of Health guidelines and with approval from the Animal Care and Use
Committee of Washington University School of Medicine. Mice were housed on a
12-h light-dark cycle (6:00 a.m. to 6:00 p.m.) and were allowed free access to food
and water. All animals were bred onto C57BL/6J background and no more than 5
animals were housed per cage. Male littermates between 8–12 weeks old were used
for experiments. Slc32a1tm2Lowl (Vgat-ires-Cre), Slc17a6tm2Lowl (Vglut2-ires-Cre),
and C57BL/6J mice were purchased from Jackson Laboratories and colonies were
established in our facilities. Litters and animals were randomized at the time of
assigning experimental conditions for the whole study. Experimenters were blind to
treatment and genotype.
Viral constructs. Puriﬁed and concentrated adeno-associated viruses coding for
Cre-independent hM3Dq-mCherry (rAAV8/hSyn-hM3Dq-mCherry; 3.2 × 1012
particles/ml, Lot number: AV5359 and Lot date: 6/13/2013), hM4Di-mCherry
(rAAV8/hSyn-hM4Di-mCherry; 2 × 1012 particles/ml, Lot number: AV5360 and
Lot date: 6/6/2013),and hSyn-eGFP (rAAV8/hSyn-eGFP; 8 × 1012 particles/ml, Lot
number: AV5075 and Lot date: 10/12/2012) was used as used as control for non
Cre dependent studies in C57 mice. Cre-dependent hM3Dq-mCherry(rAAV5/
hSyn-DIO-hM3Dq-mCherry; 6 × 1012 particles/ml, Lot number: AV4495c and Lot
date: 02/23/2012) and hM4D-mCherry (rAAV5/hSyn-DIO-hM4Di-mCherry; 6 ×
1012 particles/ml, Lot number: AV4496c and Lot date: 11/20/2012) Control
mCherry (rAAV5/hSyn-DIO-mCherry; 3.4 × 1012 particles/ml, Lot number:
AV5360 and Lot date: 04/09/2015) was used to express in the Vgat and Vglut2 Cre
mice. All vectors were packaged by the University of North Carolina Vector Core
Facility. All vectors were aliquoted and stored in −80 °C until use. We functionally
veriﬁed and validated DREADD constructs we used in this study in our prior
publication36.

Activation

vlPAG neurons

+

wherein selective activation and inhibition of speciﬁc subsets of
vlPAG GABAergic or glutamatergic neurons produces distinct
phenotypes. These ﬁndings point to the essential role of descending supraspinal circuitry in modulating itch processing, and
also support previous studies suggesting the likely existence of
strong descending itch modulation pathways14,15. Finally, the
unexpected differences observed between global pharmacologic
inhibition, global modulation of resident neuronal activity and
cell-type-selective modulation illustrate the importance of celltype-speciﬁc approaches, and provide a clear case for their use in
reexamination of basic tenets of neural circuitry.

Stereotaxic Surgeries. Mice were anesthetized with 1.5 to 2.0% isoﬂurane in a gas
chamber using isoﬂurane/breathing air mix. Once deeply anesthetized, they were
placed and secured in a stereotactic frame (David Kopf Instruments, Tujunga, CA)
where surgical anesthesia was maintained using 2% isoﬂurane. Mice were kept on a
heating pad for the duration of the procedure. Preoperative care included application of sterile eye ointment for lubrication, administration of 1 mL of subcutaneous saline and surgery site sterilization with iodine solution. A small midline
dorsal incision was performed to expose the skull and viral injections were performed using the following coordinates: vlPAG, −4.8 to 4.9 mm from bregma, +/−
0.3 to 0.4 mm lateral from midline and 2.7 to 2.9 mm ventral to skull. Viruses were
delivered bilaterally, using a stereotaxic mounted syringe pump (Micro4 Microsyringe Pump Controller from World Precision Instruments) and a custom 2.0 µL
Hamilton syringe. Injections of 150 nL of the desired viral vectors into the area of
interest were performed at a rate of 1 µL per 10 min. We allowed for a 10-min
period post injection for bolus diffusion before removing the injection needle.
Postoperative care included closure of the cranial incision with sutures and using
veterinary tissue adhesive and application of topical triple antibiotic near the
incision site. Animals were monitored while on a heating pad until they full
recovery from the anesthetic.
Cannula Implantation and lidocaine infusion. The surgical protocol was the same
as the described above for viral injections. Stainless steel guide cannulas (8 mm)
were implanted at the vlPAG and ﬁxed to the skull using two bone screws (CMA
anchor screws, #7431021) and dental cement. An 8 mm stylet was used to avoid
guide cannula clogging. Mice were allowed to recover for 7 days. Microinjections of
0.25 μl 4% lidocaine (Sigma, L1663) diluted in 0.9% saline were performed 15 min
before pruritic agent induced scratching behavior was assessed. Mice were later
euthanized, and cannula placements were veriﬁed using cresyl violet nissl stain.
Animals in which cannula’s were not placed in the vlPAG are excluded from
the study.
Chemogenetic manipulation. For non-speciﬁc chemogenetic control of vlPAG
neurons, C57BL/6J mice were injected with non-Cre dependent control eGFP,
hM3Dq or hM4Di viruses. For subpopulation speciﬁc chemogenetic control of
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vlPAG neurons Vgat-ires-Cre and Vglut2-ires-Cre mice were injected with Cre
dependent control mCh, hm3Di or hm4Dq viruses. DREADD constructs used in
this study were validated previously for their functional expression in the PAG,
including their ability to increase (hM3Dq) or decrease (hM4Di) neuronal ﬁring in
slices from animals expressing these viral constructs36. Three weeks later mice were
injected with (C57BL/6 J, VGlut2 Cre and VGAT Cre, respectively) clozapine Noxide (CNO, BML-NS105 from Enzo life sciences) 2 h before doing behavioral
experiments and data were collected between the second-hour and third-hour postinjection. All baselines for pruritic responses were recorded 2 weeks after the virus
injections and one week prior to the CNO administration. We performed dose
response studies of CNO to determine the optimal dose for use in behavioral
experiments. Based on these dose-ﬁnding studies, we selected 5 mg/kg CNO as a
dose of CNO that produces near maximal effects in Cre dependent DREADDexpressing animals and showed no signs of behavioral affects in control vectorexpressing animals. For non-Cre dependent studies, we observed that a dose above
1 mg/kg CNO was lethal, so we used 1 mg/kg CNO dose for both activation and
inhibition of vlPAG neurons.
Pruritic agent induced scratching behaviors. The nape of the neck mice was
shaved one day prior to experiments. Mice then were placed in clear plexiglass
behavioral boxes for at least two hours for acclimation for baselines41. For chemogenetic manipulations, CNO was administered before placing the mice in the
plexiglass behavioral boxes and chloroquine (200 µg/50 µl, nape of the neck)
induced scratching behavior was performed 90 min after the CNO administration.
Acetone and ether, water (AEW) induced itch. To model dry skin-mediated
itch, spontaneous scratching behavior was induced by treatment twice daily with an
acetone/diethylether (1:1) solution for 15 s followed by water for 30 s on the nape
of the neck. Following seven days of AEW treatment, spontaneous behavior was
video recorded for two hour pre-CNO and post-CNO. Scratch bouts directed to the
nape of the neck and rostral back were counted in 5-min intervals during blinded
off-line analysis.
Conditioned place aversion (CPA). CPA was performed using an unbiased,
counterbalanced three-compartment conditioning apparatus. Each chamber had a
unique combination of visual, properties (one side had black and white vertical
walls, whereas the other side had black and white striped walls). On the preconditioning day (day 1), mice were allowed free access to all three chambers for
20 min. Behavioral activity in each compartment was monitored and recorded with
a video camera and analyzed using Ethovision 8.5 (Noldus) or ANY-Maze softward. Mice were randomly assigned to saline and chloroquine compartments and
received a saline injection (50 µl) on the nape of the neck and on the mouse caudal
back, in the morning and a chloroquine injection (400 µg/50 µl) on the nape of the
neck and on the mouse caudal back in the afternoon, at least 4 h after the morning
training on 3 consecutive days (Day 2, 3, and 4). To enhance the association of
chloroquine induced scratching behavior with the paired chamber, we administered chloroquine and left the mice in their holding cage for 4 min, then placed
them in the paired chamber during the time of the peak scratching response (20
min in the chamber). To assess for place aversion, the mice were then allowed free
access to all three compartments on day 5 for 30 min61. Scores were calculated by
subtracting the time spent in the chloroquine-paired compartment, post-test minus
the pre-test. To test the effect of DREADD hM3Dq activation on chloroquineinduced place aversion, mice injected with AAV8 hM3Dq–mCherry and AAV8
EGFP were allowed free access to all three chambers for 30 min on the preconditioning day (day 1). On day 2, 3, and 4, both mice cohorts received a saline
injection (50 µl) on the nape of the neck and on the mouse caudal back, and this
chamber is paired with systemic saline injection 2 h before they were placed in the
compartment in the morning and a chloroquine injection (400 µg/50 µl) on the
nape of the neck and on the mouse caudal back and this chamber is paired with
systemic CNO injection 2 h before they were placed in the compartment in the
afternoon. To test the effect of DREADD hM3Dq activation on chloroquineinduced place aversion, the mice were allowed free access to the three compartments on day 5 for 30 min. Scores were calculated by subtracting the time spent in
the chloroquine-paired compartment, post-test minus the pre-test.
Fiber Photometry. For in vivo calcium imaging of vlPAG GABAergic and glutamatergic neurons, we injected vlPAG with Cre-dependent GCaMP6s (AAV-DJ
EF1a-DIO-GCaMP6s, 3 × 1013 particles/ml, Stanford vector core). Fiber optic
probes were unilaterally implanted above the left vlPAG (−4.8 to 4.9 mm from
bregma, +/− 0.3 to 0.4 mm lateral from midline and 2.7 to 2.9 mm ventral to
skull). After 4 weeks of viral expression, mice were handled and acclimated,
tethered as during imaging, for 7 days in the test behavioral chamber. On test day,
mice were habituated with the tethered ﬁber optic patch cord (0.48NA, BFH48400, Doric lenses) in the test chamber (15 × 15 cm) for 30 min and injected with
chloroquine (200ug/50ul) on the nape of the neck and recordings were performed.
A ﬁber optic patch cord was used to connect to the ﬁber implant and deliver
light to excite and record the GCAMP signal using a custom-built ﬁber photometry
rig. The ﬁber photometry recording setup was built with some modiﬁcations to
previously described speciﬁcations38. Fluorescence excitation was provided by two
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LEDs at 211 and 537 Hz to avoid picking up room lighting (M405FP1, M470F1;
LED driver: LEDD1B; Thorlabs) was bandpass ﬁltered (FMC1 + (405/10) -(475/
28)_(525/45)_FC), Doric lenses) and delivered to the vlPAG to excite GCaMP6s.
The emitted light was bandpass ﬁltered (FMC1 + _(405/10)-(475/28)_(525/45)
_FC), Doric lenses) and sent to a photoreceiver to detect the signal (Newport,
2151). The signal from the photoreceiver was recorded using a RZ5P real-time
processor (TDT). Data were acquired at 10 kHz and then demodulated at 211 and
537 Hz. The demodulated signal was then low-pass ﬁltered (4 Hz) in a custom
MATLAB script. The extracted 405 nm signal was then scaled to ﬁt the GCaMP
signal for the recording session. To isolate the movement-corrected GCaMP signal
from channel, we subtracted the signal at 405 nm from the 475 nm GCaMP signal.
dF/F was obtained by dividing the ﬁnal signal with its mean value. Behavioral event
timestamps associated with chloroquine evoked scratching behavior were scored
and aligned with GCAMP signal in the MATLAB script to create pre-stimulus and
peri-stimulus time bins. To obtain pre-stimulus and peri-stimulus chloroquine
evoked scratching events, if the scratching events happened to close to each other
in a 30 s window, they we combined and called as one event. Z-score was obtained
by subtracting the mean of the GCaMP signal from the bin value of the GCaMP
signal and dividing it with the standard deviation of the bin value of the GCaMP
signal.

Fluorescence in situ hybridization (FISH). For non-speciﬁc chemogenetic control
of vlPAG neurons, C57BL/6 J mice were injected with non-Cre dependent control
mCh, hM3Dq or hM4Di viruses. Three weeks later mice were injected with CNO
(BML-NS105 from Enzo life sciences) 2 hrs before chloroquine was injected on the
nape of the neck. Thirty minutes post chloroquine administration, mice were
rapidly decapitated, cervical spinal cords were dissected and ﬂash frozen in −50 °C
2-methylbutane and stored at −80 °C for further processing. Coronal sections of
the spinal cord corresponding to the cervical level, were cut at 15 μM at −20°C and
thaw-mounted onto Super Frost Plus slides (Fisher). Slides were stored at −80 °C
until further processing. FISH was performed according to the RNAScope® 2.0
Fluorescent Multiple Kit v2 User Manual for Fresh Frozen Tissue (Advanced Cell
Diagnostics, Inc.)62. Slides containing spinal cord sections were ﬁxed in 4% paraformaldehyde, dehydrated, and pretreated with protease IV solution for 30 min.
Sections were then incubated with target probes for mouse cFos (mm-Fos, catalog
number 316921, Advanced Cell Diagnostics). Following probe hybridization, sections underwent a series of probe signal ampliﬁcation steps (AMP1–4) followed by
incubation of ﬂuorescent probes (Alexa 488, Opal 470), designed to target the
speciﬁed channel associated with the probes. Slides were counterstained with DAPI
and coverslips were mounted with Vectashield Hard Set mounting medium
(Vector Laboratories). Images were obtained on a Leica TCS SPE confocal
microscope (Leica), and Application Suite Advanced Fluorescence (LAS AF)
software was used for analyses. To quantify number of cFos+ve cells, we counted
DAPI-stained nuclei that coexpress minimum of ﬁve cFos puncta as an cFos+ve
cell. We did not include any cFos puncta that does not overlay on top of the DAPIstained nuclei as part of our analysis.

Immunohistochemistry. Adult mice were deeply anesthetized using a ketamine/
xylazine cocktail and then perfused with 20 ml of with phosphate-buffered saline
(PBS) and 4% paraformaldehyde (weight/volume) in PBS (PFA; 4 °C). Brains were
carefully removed, post ﬁxed in 4% PFA overnight and later immersed in 30%
sucrose for at least 48 h. Tissues were mounted in OCT while allowing solidiﬁcation of the mounting medium at −80 °C. Using a cryostat, 30μm tissue sections
were collected and stored in PBS1× 0.4% sodium azide at 4 °C. After washing the
sections in PBS1×, we blocked using 5% normal goat serum and 0.2% Triton-X PBS
1× for one hour at room temperature. Primary antibodies against mCherry
(Mouse, Clontech, 632543; 1/500) and GFP (rabbit polyclonal anti-GFP, Aves
A11122; 1/500) were diluted in blocking solution and incubated overnight at 4 °C.
After three 10-min washes in PBS1×, tissues were incubated for one hour at room
temperature with secondary antibodies (Life Technologies: Alexa Fluor488 donkey
anti rabbit IgG (1/300); Alexa Fluor 488 goat anti rabbit (1/300); Alexa Fluor 555
goat anti mouse (1/300)) and Neurotrace (435/455 nm, 1/500) at room temperature. Three PBS1× washes followed before sections were mounted with Vectashield
(H-1400) hard mounting media and imaged after slides cured. Images were
obtained on a Nikon Eclipse 80i epiﬂuorescence microscope63–66.

Statistics. Throughout the study, researchers were blinded to all experimental
conditions. Exclusion criteria for our study consisted on a failure to localize
expression in our experimental models or off-site administration of virus or drug.
At least 3 replicates measurements were performed and averaged in all behavioral
assays. The number of animals used is indicated by the “N” in each experiment.
When paired t test was used for comparing paired observations, we evaluated for
normality using the D’Agostino and Pearson omnibus normality test for all
datasets. Therefore, only when normality could be assumed, we used a parametric
test to analyze out data. If normality could not be assumed, a nonparametric test or
a Wilcoxon matched pairs text was used to evaluate differences between the means
of our experimental groups. Two-way ANOVA was used for comparing between
different control and treatment groups. Bonferroni’s post hoc tests were used
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(when signiﬁcant main effects were found) to compare effects of variables. A value
of p < 0.05 was considered statistically signiﬁcant for all statistical comparisons.

Data availability
The data that support the ﬁndings of this study are available from the corresponding
author upon reasonable request. Source data underlying Figs. 1–9 and Supplementary
Figs. 1–3 are available as a Source Data ﬁle.

Code availability
Matlab code used in this study is available from the corresponding author upon
reasonable request.
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